questionsmedicales.fr
Virus
Virus à ARN
Virus à ARN de polarité négative
Arenaviridae
Arenavirus
Arénavirus de l'Ancien Monde
Arénavirus de l'Ancien Monde : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Arénavirus de l'Ancien Monde : Questions médicales les plus fréquentes",
"headline": "Arénavirus de l'Ancien Monde : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Arénavirus de l'Ancien Monde : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-19",
"dateModified": "2025-03-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Arénavirus de l'Ancien Monde"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Arenavirus",
"url": "https://questionsmedicales.fr/mesh/D018050",
"about": {
"@type": "MedicalCondition",
"name": "Arenavirus",
"code": {
"@type": "MedicalCode",
"code": "D018050",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.500.070"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Virus de Lassa",
"alternateName": "Lassa virus",
"url": "https://questionsmedicales.fr/mesh/D007836",
"about": {
"@type": "MedicalCondition",
"name": "Virus de Lassa",
"code": {
"@type": "MedicalCode",
"code": "D007836",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.500.070.100.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Virus Lujo",
"alternateName": "Lujo virus",
"url": "https://questionsmedicales.fr/mesh/D063927",
"about": {
"@type": "MedicalCondition",
"name": "Virus Lujo",
"code": {
"@type": "MedicalCode",
"code": "D063927",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.500.070.100.525"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Virus de la chorioméningite lymphocytaire",
"alternateName": "Lymphocytic choriomeningitis virus",
"url": "https://questionsmedicales.fr/mesh/D008217",
"about": {
"@type": "MedicalCondition",
"name": "Virus de la chorioméningite lymphocytaire",
"code": {
"@type": "MedicalCode",
"code": "D008217",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.480.500.070.100.550"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Arénavirus de l'Ancien Monde",
"alternateName": "Arenaviruses, Old World",
"code": {
"@type": "MedicalCode",
"code": "D018049",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Slobodan Paessler",
"url": "https://questionsmedicales.fr/author/Slobodan%20Paessler",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Galveston National Laboratory and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA."
}
},
{
"@type": "Person",
"name": "Susan R Ross",
"url": "https://questionsmedicales.fr/author/Susan%20R%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL 60612 srross@uic.edu."
}
},
{
"@type": "Person",
"name": "Mathieu Mateo",
"url": "https://questionsmedicales.fr/author/Mathieu%20Mateo",
"affiliation": {
"@type": "Organization",
"name": "Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France."
}
},
{
"@type": "Person",
"name": "Sylvain Baize",
"url": "https://questionsmedicales.fr/author/Sylvain%20Baize",
"affiliation": {
"@type": "Organization",
"name": "Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France. sylvain.baize@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Junki Maruyama",
"url": "https://questionsmedicales.fr/author/Junki%20Maruyama",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Galveston National Laboratory and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neurophysiopathological Aspects of Paclitaxel-induced Peripheral Neuropathy.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36169871",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12640-022-00582-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer.",
"datePublished": "2023-10-14",
"url": "https://questionsmedicales.fr/article/37839313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ygyno.2023.09.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Paclitaxel-induced dorsal hand-foot syndrome.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37591274",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5070/D329361434"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of Priming Strategy for Enhanced Paclitaxel Biosynthesis in",
"datePublished": "2022-06-29",
"url": "https://questionsmedicales.fr/article/35805152",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells11132062"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37520574",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1175809"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN de polarité négative",
"item": "https://questionsmedicales.fr/mesh/D000086103"
},
{
"@type": "ListItem",
"position": 5,
"name": "Arenaviridae",
"item": "https://questionsmedicales.fr/mesh/D001116"
},
{
"@type": "ListItem",
"position": 6,
"name": "Arenavirus",
"item": "https://questionsmedicales.fr/mesh/D018050"
},
{
"@type": "ListItem",
"position": 7,
"name": "Arénavirus de l'Ancien Monde",
"item": "https://questionsmedicales.fr/mesh/D018049"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Arénavirus de l'Ancien Monde - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Arénavirus de l'Ancien Monde",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Arénavirus de l'Ancien Monde",
"description": "Comment diagnostiquer une infection par arénavirus ?\nQuels tests sont utilisés pour les arénavirus ?\nLes symptômes aident-ils au diagnostic ?\nQuand faire un test pour arénavirus ?\nLes tests sont-ils fiables pour tous les arénavirus ?",
"url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Paclitaxel&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Arénavirus de l'Ancien Monde",
"description": "Quels sont les symptômes courants des arénavirus ?\nLes symptômes varient selon le virus ?\nY a-t-il des symptômes spécifiques aux arénavirus ?\nLes symptômes apparaissent-ils rapidement ?\nLes symptômes peuvent-ils être graves ?",
"url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Paclitaxel&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Arénavirus de l'Ancien Monde",
"description": "Comment prévenir les infections par arénavirus ?\nLes vaccins existent-ils pour les arénavirus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes voyages dans certaines zones sont-ils risqués ?\nLes rongeurs doivent-ils être contrôlés ?",
"url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Paclitaxel&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Arénavirus de l'Ancien Monde",
"description": "Quel est le traitement des infections par arénavirus ?\nLes antibiotiques sont-ils efficaces contre les arénavirus ?\nComment gérer les symptômes graves ?\nY a-t-il des antiviraux pour les arénavirus ?\nLe traitement préventif est-il possible ?",
"url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Paclitaxel&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Arénavirus de l'Ancien Monde",
"description": "Quelles complications peuvent survenir ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?\nLes complications peuvent-elles être mortelles ?\nY a-t-il des séquelles après l'infection ?",
"url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Paclitaxel&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Arénavirus de l'Ancien Monde",
"description": "Qui est à risque d'infection par arénavirus ?\nLes travailleurs de la santé sont-ils plus exposés ?\nLes voyageurs sont-ils à risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLes enfants sont-ils plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Paclitaxel&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par arénavirus ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et PCR pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les arénavirus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques, PCR et culture virale sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic, mais ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Quand faire un test pour arénavirus ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test doit être effectué si des symptômes de fièvre hémorragique apparaissent."
}
},
{
"@type": "Question",
"name": "Les tests sont-ils fiables pour tous les arénavirus ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fiabilité peut varier selon le type d'arénavirus et le test utilisé."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des arénavirus ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, fatigue, douleurs musculaires et hémorragies."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type d'arénavirus infectant."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux arénavirus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des saignements et des éruptions cutanées peuvent être spécifiques."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, généralement dans les 1 à 2 semaines."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être graves ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cas peuvent évoluer vers des formes graves, nécessitant une attention médicale."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par arénavirus ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le contact avec les rongeurs et leurs excréments est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour les arénavirus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins approuvés pour les arénavirus de l'Ancien Monde."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène, comme le nettoyage régulier, aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines zones sont-ils risqués ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'infection par arénavirus."
}
},
{
"@type": "Question",
"name": "Les rongeurs doivent-ils être contrôlés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contrôle des populations de rongeurs est crucial pour réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quel est le traitement des infections par arénavirus ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique ; le soutien symptomatique est essentiel."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les arénavirus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales comme celles-ci."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes graves ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes graves nécessitent une hospitalisation et des soins intensifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des antiviraux pour les arénavirus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiquement approuvés pour les arénavirus."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il possible ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement préventif, mais la vaccination est en cours d'étude."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des hémorragies, des défaillances organiques et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares mais peuvent survenir dans des cas sévères."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite des soins médicaux intensifs et un suivi rigoureux."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent être mortelles, surtout sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Y a-t-il des séquelles après l'infection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des séquelles peuvent survenir, notamment des problèmes neurologiques ou respiratoires."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'infection par arénavirus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes en contact avec des rongeurs ou vivant dans des zones endémiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils plus exposés ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés lors de soins à des patients infectés."
}
},
{
"@type": "Question",
"name": "Les voyageurs sont-ils à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs dans des régions endémiques courent un risque accru d'infection."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées peuvent avoir un risque accru de complications graves."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent être à risque, mais les adultes sont généralement plus touchés par les complications."
}
}
]
}
]
}
Chemotherapy is widely used as a primary treatment or adjuvant therapy for cancer. Anti-microtubule agents (such as paclitaxel and docetaxel) are used for treating many types of cancer, either alone o...
This phase 2 study investigated sapanisertib (selective dual inhibitor of mTORC1/2) alone, or in combination with paclitaxel or TAK-117 (a selective small molecule inhibitor of PI3K), versus paclitaxe...
Patients with histologic diagnosis of endometrial cancer (1-2 prior regimens) were randomized to 28-day cycles on four treatment arms: 1) weekly paclitaxel 80 mg/m...
Of 241 patients randomized, 234 received treatment (paclitaxel, n = 87 [3 ongoing]; paclitaxel+sapanisertib, n = 86 [3 ongoing]; sapanisertib, n = 41; sapanisertib+TAK-117, n = 20). The sapanisertib a...
Our findings support inclusion of chemotherapy combinations with investigational agents for advanced or metastatic disease. The primary endpoint was not met and toxicity was manageable....
ClinicalTrials.gov number, NCT02725268....
Hand-foot syndrome (HFS), also known as palmoplantar erythrodysesthesia or acral erythema, is a known adverse effect of chemotherapeutic agents that most commonly presents as palmoplantar dysesthesia ...
Despite huge progress in biotechnological approaches to paclitaxel production,...
The combination of nanoparticle albumin-bound paclitaxel (nab-PTX)/paclitaxel (PTX) with immune checkpoint inhibitors (ICIs) has demonstrated significant efficacy in cancer patients. However, the safe...
We performed a systematic review by searching randomized controlled trials (RCTs) from PubMed, EMBASE, Cochrane Library, ClinicalTrials.gov, and Web of Science up to August 15, 2022. The primary outco...
There were 22 RCTs included in the NMA, involving a total of 15 963 patients diagnosed with any type of cancer. ICIs+nab-PTX was associated with a noticeably decreased risk of grade 3-5 pneumonitis (o...
Nab-PTX/PTX+ICIs demonstrated an approach leading to decreased risk of irAEs compared with ICI monotherapy. This finding supports that ICIs+nab-PTX/PTX may be a safer treatment strategy. Moreover, we ...
Co-delivery of anticancer drugs and target agents by endogenous materials is an inevitable approach towards targeted and synergistic therapy. Employing DNA base pair complementarities, DNA nanotechnol...
Taxanes (Taxol/paclitaxel, Docetaxel/taxotere) are a key group of successful drugs commonly used in chemotherapy to treat several major malignant tumors also as a front-line agent in combination with ...
Nab-PTX is a special dosage form of antitumor drug that is different from other injections. In order to explore the efficacy and safety of albumin-bound paclitaxel, we developed an analytical method w...
Pancreatic cancer (PC) is an incurable disease with a high death rate in the world nowadays. Gemcitabine (GEM) and Paclitaxel (PTX) are considered as references of chemotherapeutic treatments and are ...
Propofol is a drug with potential anticancer effect. This study aimed to explore the effect of propofol on chemosensitivity of cervical cancer cells to paclitaxel....
HeLa and CaSki cells were selected for drug experiments. Cell viability was evaluated via CCK-8 assay, and the combination index (CI) was calculated by CompuSyn software. A clinically relevant concent...
At clinically relevant concentrations (0-80 μM), propofol did not affect cancer cell viability, but high concentrations (100-800 μM) reduced cell viability. The CI values of propofol with IC30 (200 μM...
Propofol at clinically relevant concentrations had no effect on the malignant biological behaviors of cervical cancer cells, while propofol at high concentrations decreased.Propofol with IC30 and pacl...